메뉴 건너뛰기




Volumn 109, Issue 10, 2012, Pages 1510-1513

Predictors of hyperkalemia and death in patients with cardiac and renal disease

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM SPARING DIURETIC AGENT;

EID: 84860493488     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.367     Document Type: Article
Times cited : (185)

References (20)
  • 2
    • 72449208198 scopus 로고    scopus 로고
    • Hyperkalemia in patients with heart failure: Incidence, prevalence, and management
    • A. Desai Hyperkalemia in patients with heart failure: incidence, prevalence, and management Curr Heart Fail Rep 6 2009 272 280
    • (2009) Curr Heart Fail Rep , vol.6 , pp. 272-280
    • Desai, A.1
  • 3
    • 0018831590 scopus 로고
    • Hyperkalemia and hyporeninemic hypoaldosteronism
    • R.A. DeFronzo Hyperkalemia and hyporeninemic hypoaldosteronism Kidney Int 17 1980 118 134
    • (1980) Kidney Int , vol.17 , pp. 118-134
    • Defronzo, R.A.1
  • 5
    • 64149098797 scopus 로고    scopus 로고
    • Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients
    • B. Wozakowska-Kapon, I. Janowska-Molenda Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients Pol Arch Med Wewn 119 2009 141 147
    • (2009) Pol Arch Med Wewn , vol.119 , pp. 141-147
    • Wozakowska-Kapon, B.1    Janowska-Molenda, I.2
  • 11
    • 31644438457 scopus 로고    scopus 로고
    • Cardiovascular risk factors in chronic kidney disease
    • V. Menon, A. Gul, M.J. Sarnak Cardiovascular risk factors in chronic kidney disease Kidney Int 68 2005 1413 1418
    • (2005) Kidney Int , vol.68 , pp. 1413-1418
    • Menon, V.1    Gul, A.2    Sarnak, M.J.3
  • 12
    • 33748713630 scopus 로고    scopus 로고
    • Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: A retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials
    • S. de Denus, J.-C. Tardif, M. White, M.G. Bourassa, N. Racine, S. Levesque, A. Ducharme Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials Am Heart J 152 2006 705 712
    • (2006) Am Heart J , vol.152 , pp. 705-712
    • De Denus, S.1    Tardif, J.-C.2    White, M.3    Bourassa, M.G.4    Racine, N.5    Levesque, S.6    Ducharme, A.7
  • 13
    • 41149101190 scopus 로고    scopus 로고
    • Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: A systematic review and meta-analysis of randomized controlled trials
    • R. Lakhdar, M.H. Al-Mallah, D.E. Lanfear Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials J Card Fail 14 2008 181 188
    • (2008) J Card Fail , vol.14 , pp. 181-188
    • Lakhdar, R.1    Al-Mallah, M.H.2    Lanfear, D.E.3
  • 14
    • 35348976721 scopus 로고    scopus 로고
    • Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: A quantitative review of data from randomized clinical trials
    • C.O. Phillips, A. Kashani, D.K. Ko, G. Francis, H.M. Krumholz Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials Arch Intern Med 167 2007 1930 1936
    • (2007) Arch Intern Med , vol.167 , pp. 1930-1936
    • Phillips, C.O.1    Kashani, A.2    Ko, D.K.3    Francis, G.4    Krumholz, H.M.5
  • 15
    • 0035901585 scopus 로고    scopus 로고
    • Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
    • J.F.E. Mann, H.C. Gerstein, J. Pogue, J. Bosch, S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
    • (2001) Ann Intern Med , vol.134 , pp. 629-636
    • Mann, J.F.E.1    Gerstein, H.C.2    Pogue, J.3    Bosch, J.4    Yusuf, S.5
  • 16
    • 1042264337 scopus 로고    scopus 로고
    • What is the optimal serum potassium level in cardiovascular patients?
    • J.E. Macdonald, A.D. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2004 155 161
    • (2004) J Am Coll Cardiol , vol.43 , pp. 155-161
    • MacDonald, J.E.1    Struthers, A.D.2
  • 17
    • 55949112567 scopus 로고    scopus 로고
    • Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
    • B. Pitt, G. Bakris, L.M. Ruilope, L. DiCarlo, R. Mukherjee Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Circulation 118 2008 1643 1650
    • (2008) Circulation , vol.118 , pp. 1643-1650
    • Pitt, B.1    Bakris, G.2    Ruilope, L.M.3    Dicarlo, L.4    Mukherjee, R.5
  • 19
    • 21244497660 scopus 로고    scopus 로고
    • The mineralocorticoid receptor and oxidative stress
    • A. Fiebeler, F.C. Luft The mineralocorticoid receptor and oxidative stress Heart Fail Rev 10 2005 47 52
    • (2005) Heart Fail Rev , vol.10 , pp. 47-52
    • Fiebeler, A.1    Luft, F.C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.